In vitro susceptibility of Mycobacterium tuberculosis to trimethoprim and sulfonamides in France
- PMID: 24060877
- PMCID: PMC3837923
- DOI: 10.1128/AAC.01683-13
In vitro susceptibility of Mycobacterium tuberculosis to trimethoprim and sulfonamides in France
Abstract
Five type strains and 55 Mycobacterium tuberculosis complex clinical isolates were found resistant to trimethoprim with a MIC of >200 mg/liter and susceptible to both sulfadiazine and cotrimoxazole with a MIC90 of 10 mg/liter. Two M. canettii isolates uniquely yielded silent mutations C156 → T and G238 → C in the folP1 gene. Combined with scarce published data, these data indicate that sulfamides could be considered alternative antituberculous antibiotics.
References
-
- World Health Organization 2012. Global tuberculosis report. NLM classification: WF 300. World Health Organization, Geneva, Switzerland: http://www.who.int/tb/publications/global_report/gtbr12_main.pdf
-
- Nzila A, Ma Z, Chibale K. 2011. Drug repositioning in the treatment of malaria and TB. Future Med. Chem. 3:1413–1426 - PubMed
-
- Fauci AS. 2008. Multidrug-resistant and extensively drug-resistant tuberculosis: the National Institute of Allergy and Infectious Diseases research agenda and recommendations for priority research. J. Infect. Dis. 197:1493–1498 - PubMed
-
- Brown GM. 1962. The biosynthesis of folic acid. II. Inhibition by sulfonamides. J. Biol. Chem. 237:536–540 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
